Evaluates succinic semialdehyde dehydrogenase (SSADH) deficiency severity using CSF and urine 4-hydroxybutyric acid (GHB), EEG abnormalities, and neuropsychiatric features to guide vigabatrin response assessment.
Evaluates succinic semialdehyde dehydrogenase (SSADH) deficiency severity using CSF and urine 4-hydroxybutyric acid (GHB), EEG abnormalities, and neuropsychiatric features to guide vigabatrin response assessment
Each component has a specific meaning:
Note: Interpret the ssadh deficiency result against the thresholds and context described above.
Enter the CSF, urine 4-hydroxybutyric acid, EEG abnormalities, neuropsychiatric features for the scenario you are assessing. Evaluates succinic semialdehyde dehydrogenase (SSADH) deficiency severity using CSF and urine 4-hydroxybutyric acid (GHB), EEG abnormalities, and neuropsychiatric features to guide vigabatrin response assessment. Use the ssadh deficiency result to inform your calculation.